DRUG FLURENISID AS AN IMMUNOMODULATOR FOR THE TREATMENT OF ORPHAN DISEASES
Journal Title: Праці Наукового товариства ім. Шевченка - Year 2017, Vol 50, Issue 1
Abstract
Flurenizide was created as a result of purposeful synthesis of fl uorene series compounds and research into their chemical, physical, biological and pharmacological characteristics. The study was directed at converting low-molecular chemical compounds into medication according to the following scheme: «biologically active substance → pharmacological compound → medication». The further task was to turn the idea into reality and create a new effective medication. It was necessary to consistently go through a long way, which includes related disciplines «science → technology → production → pharmacology → medicine → treatment standards». Based on biological studies in vitro and in vivo, antimicrobial and antiviral effects of Flurenizide and others new fl uorenes were detected on different strains of microorganisms and types of viruses. Preclinical pharmacological and experimental clinical trials of Flurenizide were made owing to close scientifi c collabo-ration between scientists from research laboratories members of medical institutions departments, research and production enterprises etc. Basic aspects: • extensive preclinical and clinical investigation of new biologically active compounds of fl uorene series as a promising chemotherapeutic products for medicine and veterinary medicine. • microbiological, pharmacological, pharmaco-technological and clinical study of antituberculous, anti-chlamidia, antimicrobial, immunomodulating and antiviral Flurenizide medication and farmaceutical forms based on it. Flurenizide is introduced into Ukrainian production standards and standards in healthcare institutions of medicosanitary help. Based on an innovative product – an original Ukrainian substance of Flurenizide, promising dosage forms for different branches of medicine was created. Owing to joint efforts, worthy contributions were made to the development of Ukrainian pharmaceutical and medical science, to domestic production of effective and safe medicines. Flurenizide (code G01A X) is available in the project «Reference list of preparations that could be used to prove the equivalence of medications». Flurenisid – preparation of a new class (class fl uorene) is proposed for use in the treatment of viral infections, immunodefi ciencies and rare diseases.
Authors and Affiliations
Мaria Kovalenko
Keywords
Related Articles
- EP ID EP325418
- DOI 10.25040/ntsh2017.02.075
- Views 50
- Downloads 0
KINETICS OF SILVER NANOPARTICLES FORMATION IN THE PRESENCE OF NUCLEATION CENTERS
The kinetics of formation of silver nanoparticles via reduction of silver nitrate by hydrazine hydrate in the presence of added into the reaction medium silver nucleation centers with mean diameter 15 nm have been invest...
THE SANATSIYA PROJECT — DENTAL CARE FOR ENLISTED SOLDIERS
A year and a half ago, the Sanatsiya charity project was created with the efforts of concerned dentists. A volunteer dentist’s office was established at the Yavorivs’k polygon, where dentists provide expert care to enlis...
ACQUIREMENT AND IMPROVEMENT OF PRACTICAL SKILLS IN STUDENT’S CIRCLE IN THE CONTEXT OF PREPARING FUTURE DOCTORS TO WORK INDEPENDENTLY
The important role in the formation of future doctor plays different types of independent work – both in the form of compulsory training program, which is a part of ECTS credits of each discipline and in the form of prac...
FEATURES OF STRESS INDICATORS IN REPRESENTATIVES OF ABNORMAL POLITICAL PARTICIPATION
The results of preliminary surveys indicated that level of knowledge and understanding of citizens and young people how to engage with authorities and have the opportunity to defend their own interests is insuffi cient....
PROFESSOR BORYS ZIM ENKOVSKY’S SCIENTIFIC SCHOOL IN THE LIGHT OF M ODERN EUROPEAN SCIENTIFIC TRENDS: YESTERDAY, TODAY, TOMORROW
Scientific school investigating chemistry and pharmacological profile of azolidinones, thiazanes and related heterocycles had been developed and successfully led by prof. B. Zimenkovsky at the department o f pharmaceutic...